Purchase order for evaluation of an in vitro spinal rosette array platform
Ended Purchase Order Awarded
- Contract number
- 75F40125P00196
- Awardee
-
Neurosetta LLC UEI LKCCN9GN4BM1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $135,000
Award facts
- Contract value 100% obligated
- $135,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53717, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration (FDA) awarded a purchase order to Neurosetta LLC (doing business as Neur) on September 5, 2025, for the evaluation of an in vitro spinal rosette array platform. The contract, which is not set aside for any specific business category, carries a ceiling value of $135,000 and is structured as a firm fixed-price purchase order. Work will be performed in Madison, Wisconsin, with an ultimate completion date of September 2, 2026.
This evaluation effort supports the FDA's regulatory science mission, likely contributing to the agency's assessment of emerging in vitro testing technologies for spinal applications. In vitro rosette array platforms represent advanced cellular or tissue-based testing systems that can potentially provide more efficient and accurate alternatives to traditional testing methods. The evaluation contract will provide the FDA with critical data regarding the platform's capabilities, reliability, and potential regulatory applications, informing the agency's guidance on the qualification and acceptance of such technologies in the pharmaceutical and biotechnology sectors.
Quick answers
Who was awarded contract 75F40125P00196?
75F40125P00196 was awarded to Neurosetta LLC by Food and Drug Administration (Department of Health and Human Services) on September 5, 2025.
How much is contract 75F40125P00196 worth?
The government has obligated $135,000 on 75F40125P00196.
Was contract 75F40125P00196 competed?
The extent of competition for 75F40125P00196 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award